Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study.
about
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@en
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@nl
type
label
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@en
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@nl
prefLabel
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@en
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@nl
P2093
P2860
P356
P1476
Efficacy, safety and pharmacok ...... arm, open-label phase 2 study.
@en
P2093
Aining Sun
Stephen Songer
P2860
P304
P356
10.1111/AJCO.12835
P50
P577
2017-12-28T00:00:00Z